Cellular Remodeling of ECM Scaffolds

ECM 支架的细胞重塑

• 批准号: 7251331
• 负责人: Stephen F. Badylak
• 金额: $ 31.19万
• 依托单位: UNIVERSITY OF PITTSBURGH AT PITTSBURGH
• 依托单位国家: 美国
• 财政年份: 2007
• 资助国家: 美国
• 起止时间: 2007-04-01 至 2010-02-28
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/7251331
• 关键词: Address; Angiogenic Peptides; Animals; Antigen Presentation; Binding; Biology; Blood Vessels; Bone Marrow; Bone Marrow Cells; Bone Marrow Involvement; Cardiovascular system; Cell Lineage; Cell-Matrix Junction; Cells; Cellular biology; Chemicals; Chemotactic Factors; Cicatrix; Clinical; Collagen; Complement; Deposition; Development; Dura Mater; End Point; Esophagus; Extracellular Matrix; Extracellular Matrix Degradation; Fibroblast Growth Factor; Fibroblasts; Growth Factor; Hematopoietic; Hematopoietic stem cells; Heparitin Sulfate; Human; Inflammatory Response; Laboratories; Laminin; Ligands; Localized; Location; Lower urinary tract; Marrow; Mediating; Medicine; Modeling; Natural regeneration; Numbers; Operative Surgical Procedures; Pattern; Peptides; Placement; Play; Population; Principal Investigator; Process; Property; Recruitment Activity; Regenerative Medicine; Relative (related person); Research Personnel; Rodent Model; Role; Signal Transduction; Site; Skin; Source; Stem Cell Development; Stem cells; Structure; Subcutaneous Tissue; Testing; Thick; Time; TimeLine; Tissue Engineering; Tissues; Transgenic Organisms; Vascular Endothelial Cell; Work; Wound Healing; achilles tendon; angiogenesis; base; cell motility; clinical application; crosslink; day; implantation; in vivo; injured; migration; mouse model; neovascularization; pre-clinical; precursor cell; programs; reconstruction; repaired; scaffold; self assembly; soft tissue; transdifferentiation

DESCRIPTION (provided by applicant): Biologic scaffolds composed of extracellular matrix (ECM) have been successfully used as inductive templates for the constructive remodeling of many tissues including the lower urinary tract, skin, musculotendinous tissues and esophagus, among others in both preclinical animal studies and in human clinical applications. However, the mechanisms by which this constructive remodeling process occurs in diverse tissues is largely unknown. The source of cells that populate and participate in the ECM remodeling process is a source of controversy and the ability to control such a cell population would represent a significant technical advance in the field of regenerative medicine. The proposed work will address a very focused aspect of the cellular remodeling process. Specifically, we will examine the temporal and spatial patterns of ECM remodeling by two populations of cells: ciculating fibrocytes and local tissue fibroblasts. Circulating fibrocytes are a population of marrow derived cells of hematopoietic origin that have been shown to participate in wound healing, angiogenesis, antigen presentation, and tissue remodeling. To date, these cells have not been examined for their role in tissue reconstruction with an ECM based scaffold approach. We will examine both the bone marrow and surrounding soft tissue as potential sources of both circulating fibrocytes and local tissue fibroblasts during the remodeling process. Using chimeric and transgenic mouse models we will track selected cell populations during studies to accomplish two specific aims. The first specific aim will determine the involvement of bone marrow derived fibrocytes in the remodeling process of ECM biologic scaffolds. The second specific aim will determine the role of local tissue fibroblasts in the remodeling process. We have assembled a highly interdisciplinary team with expertise in medicine, surgery, tissue engineering, ECM biology, stem cell biology, and cellular differentiation. We have identified clearly defined specific aims with quantifiable end points and an efficient three year timeline to conduct this work.

描述（由申请人提供）：由细胞外基质（ECM）组成的生物支架已在临床前动物研究中成功用作许多组织的建设性重塑的诱导模板，包括下尿路、皮肤、肌腱组织和食道等以及在人类临床应用中的应用。然而，这种建设性重塑过程在不同组织中发生的机制在很大程度上尚不清楚。填充并参与 ECM 重塑过程的细胞来源是一个争议的来源，控制此类细胞群的能力将代表再生医学领域的重大技术进步。拟议的工作将解决细胞重塑过程的一个非常集中的方面。具体来说，我们将检查两种细胞群（循环纤维细胞和局部组织成纤维细胞）ECM 重塑的时间和空间模式。循环纤维细胞是造血起源的骨髓来源细胞群，已被证明参与伤口愈合、血管生成、抗原呈递和组织重塑。迄今为止，尚未检查这些细胞在基于 ECM 的支架方法的组织重建中的作用。我们将检查骨髓和周围软组织作为重塑过程中循环纤维细胞和局部组织成纤维细胞的潜在来源。使用嵌合和转基因小鼠模型，我们将在研究过程中跟踪选定的细胞群，以实现两个特定目标。第一个具体目标将确定骨髓来源的纤维细胞参与 ECM 生物支架的重塑过程。第二个具体目标将确定局部组织成纤维细胞在重塑过程中的作用。我们组建了一支高度跨学科的团队，拥有医学、外科、组织工程、ECM 生物学、干细胞生物学和细胞分化方面的专业知识。我们已经确定了明确的具体目标、可量化的终点和有效的三年时间表来开展这项工作。